REFERENCEGoogle News, NIFTY/SENSEX·11d★ ON YOUR LIST
Nifty Pharma Index Hits Fresh 52-Week High; Dr Reddy’s, Cipla, Ajanta Pharma Lead Rally on GLP-1 Opportunity - India InfolineStock · NSE
NIFTYPHARMA
Quote not available for NIFTYPHARMA. Yahoo Finance may not list this symbol with the .NS suffix; we'll move to a licensed feed in v2.
Positive
6
Neutral
5
Negative
0
News mentioning NIFTYPHARMA
Sentiment: +55%← All news
REFERENCEGoogle News, NIFTY/SENSEX·17d★ ON YOUR LIST
Nifty Pharma jumps nearly 2%; Dr Reddy's, Sun Pharma and Cipla lead gains, dominate Nifty gainers list - Moneycontrol.comVERIFIEDMint Markets·32d★ ON YOUR LIST
Sun Pharma, Alkem Labs, other pharma stocks gain despite stock market crash; Nifty Pharma rises for fourth day in a rowAI summary· NEUTRAL
VERIFIEDEconomic Times News·46d★ ON YOUR LIST
Nifty Pharma, 4 others hit 52-week high since Iran war while Nifty fell 7%. Will the form continue?AI summary· POSITIVE
- ·Five Indian sectors, including Pharma, Energy, Defence, Capital Markets, and Metals, have reached 52-week highs.
- ·These sectors are demonstrating strength despite a challenging market influenced by geopolitical tensions and foreign fund outflows.
- ·The rise in these sectors is attributed to structural earnings visibility and long-term growth prospects.
VERIFIEDET Markets·46d★ ON YOUR LIST
Nifty Pharma, 4 others hit 52-week high since Iran war while Nifty fell 7%. Will the form continue?AI summary· POSITIVE
- ·Five Indian sectors, including Pharma, Energy, Defence, Capital Markets, and Metals, have reached 52-week highs.
- ·These sectors are demonstrating strength despite a challenging market influenced by geopolitical tensions and foreign fund outflows.
- ·The upward trend in these sectors is attributed to structural earnings visibility and long-term growth prospects.
VERIFIEDET Stocks·46d★ ON YOUR LIST
Nifty Pharma, 4 others hit 52-week high since Iran war while Nifty fell 7%. Will the form continue?AI summary· POSITIVE
- ·Five Indian sectors, including Pharma, Energy, Defence, Capital Markets, and Metals, have reached 52-week highs.
- ·This strength is observed despite a challenging market backdrop characterized by geopolitical tensions and foreign fund outflows.
- ·The sectors' performance is attributed to structural earnings visibility and long-term growth tailwinds.
VERIFIEDMint Markets·49d★ ON YOUR LIST
Top Gainers & losers on May 22: JSW Cement, Honasa Consumer, Tata Comm, Sammaan Capital, Trent among top gainersAI summary· NEUTRAL
VERIFIEDMint Markets·50d★ ON YOUR LIST
Gland Pharma to Biocon: Pharma stocks rally up to 27% in a month: Can they shield portfolio from US-Iran war-led risks?AI summary· POSITIVE
REFERENCEGoogle News, NIFTY/SENSEX·51d★ ON YOUR LIST
Mankind Pharma, Zydus Lifesciences fuel Nifty Pharma to 52-week high; index trades 9.8% higher YTD - UpstoxVERIFIEDET Markets·51d★ ON YOUR LIST
Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?AI summary· POSITIVE
- ·Pharma stocks rallied on Wednesday, with the Nifty Pharma index reaching a new 52-week high of 25,043.
- ·The Nifty Pharma index crossed the 25,000 mark, rebounding from early losses.
- ·The rally in pharma stocks was supported by strong earnings and a weakening rupee.
VERIFIEDMint Markets·57d★ ON YOUR LIST
Top Gainers & Losers on May 14: NLC India, Cipla, Bharti Airtel, Vedanta, MCX, BSE, Berger Paints among top gainersAI summary· POSITIVE
- ·Indian equities rebounded on May 14, with benchmark indices rising over 1%.
- ·The Nifty Pharma index surged 2.73%, while the Nifty IT index fell nearly 2%.
- ·The rupee hit a record low before recovering.